BANGALORE, March 2, 2017 /PRNewswire/ --
Move Designed to Streamline Card Payment Acceptance and Enhance Patient Experience
-Innoviti to Enable Convenient POS Card Payment Acceptance and Flexible EMI Payment Options at Columbia Asia Hospitals via its uniPAY NEXT Payments Platform
Innoviti Payment Solutions Pvt. Ltd. and Columbia Asia Hospitals Pvt. Ltd. today announced a tie-up whereby Innoviti will now enable Card Payments Acceptance across all their hospitals in India. Columbia Asia is an international healthcare group operating a chain of modern hospitals across Asia. It is one of the first healthcare companies to enter India through 100% Foreign Direct Investment (FDI) route.
(Logo: http://photos.prnewswire.com/prnh/20151009/10132317 )
Under this arrangement, Innoviti will implement its award-winning uniPAY NEXT integrated payments platform to facilitate both normal card payments acceptance as well as flexible EMI card payment options to all their 11 medical facilities across the India. Additionally, uniPAY NEXT will help Columbia Asia facilitate faster card payment transactions and prevention of double debits while providing unparalleled customer insights from card transactions data and MIS analytics to help drive-targeted healthcare campaigns. The solution will streamline operations by automating reconciliation, settlement with banks and reporting thereby significantly enhancing their cashier productivity.
Extending its service to Columbia Asia Hospitals, Mr. Rajeev Agrawal, Managing Director & Chief Executive Officer of Innoviti said, "Our association with one of leading healthcare chains in India is to build a comprehensive and convenient cashless payment infrastructure to help the patients, and abide by Union Government's cashless drive in the health sector." He further added, "We aim to provide seamless and reliable payment solutions processing, with our uniPAY NEXT platform, to help the healthcare chain to offer a significantly enhanced checkout experience to all its customers while streamlining their operational costs."
"We strive to make our services flexible and user-friendly for our customers. Our association with Innoviti, will enable us to make payment options easier and the process hassle-free for our patients," said Mr. Jagannath MS, CFO & Director - Finance, Columbia Asia Hospitals Pvt. Ltd. "In keeping with the Government's push towards digital payments, we are committed towards bringing the advantages of cashless payments to our patients and their caregivers," he further added.
About Innoviti Payment Solutions Pvt. Ltd., Bangalore, India
Innoviti Payment Solutions Pvt. Ltd. (formerly Innoviti Embedded Solutions Pvt. Ltd.) has been a pioneer in the use of technology to solve real-world payment acceptance problems of merchants. Using its indigenous developed technology and constant innovation, Innoviti has delivered differentiated solutions for payments automation, consumer credit distribution and SME lending that have become a benchmark in their markets. Innoviti processes over Rs. 12,000 Cr. of payment transactions annually including Rs. 1000 Cr. of credit. Innoviti's smelending.com is #1 in the segment of SME lending, processing over Rs 400 Cr. per year. uniPAY is India's only omni-channel payment platform for managing payment automation. The company has won Deloitte Asia Pacific award three years in a row and Red Herring Asia award twice. Innoviti is backed by marquee investors such as Titan Company (JV between Tata Group and TIDCO), Catamaran Ventures and New India Investment Corporation, Canada.
For more information, please visit - http://www.innoviti.com
Media Contact: Sarath Chandra Nerella Marketing Manager Innoviti Payment Solutions Pvt. Ltd. firstname.lastname@example.org +91-7795348478
Subscribe to our Free Newsletters!
The Hib vaccine protects children against infections like meningitis and pneumonia that are caused ...
Dysthymia or persistent depressive disorder (PDD) is a chronic low mood and self-esteem affecting ...
Vitamin A is an extremely vital vitamin needed for the eyes, skin, hair, immunity and during ...View All